Seres therapeutics to participate in the morgan stanley 21st annual global healthcare conference

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that seres management will participate at the morgan stanley 21st annual global healthcare conference on monday, september 11, 2023, at 12:15 p.m. et. an audio webcast of the presentation will be available under the “investors and news” section of seres' website. a replay of the presentation will become available approximately one hour after the event and will b.
MCRB Ratings Summary
MCRB Quant Ranking